- Arbor Pharmaceuticals announces FDA approval of Sotylize™ |
- Sutro Biopharma and Celgene Corporation Enter Multi-Year Strategic Collaboration and Option to acquire Agreement |
- CSL to acquire Novartis influenza vaccine business |
- Ultragenyx granted Orphan Drug Designation for Triheptanoin for the treatment of Glucose Transporter Type-1 Deficiency Syndrome |
- QIAGEN announces broad agreement with Astellas Pharma to develop companion diagnostics |
- Araim Pharmaceuticals given FDA Fast Track Designation to ARA 290 for the Treatment of Sarcoidosis-associated Small Fiber Neuropathy |
- Research and Markets: The Russian Pharmaceutical Market is Anticipated to Grow at a CAGR of Around 11% During 2012-2017 |
- Vitro Biopharma Launches new Cell Lines to Bolster Revenue Growth |
- Xcovery Raises $20M through Equity Investment from China’s Betta Pharmaceuticals for Development of ALK Inhibitor |
- Novo Nordisk now hiring for new manufacturing facility in New Hampshire |
- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2013 |
- Imprimis Pharmaceuticals enters into License Agreement for Patented Urology Formulation |
- Global Pharmaceutical Contract Manufacturing Market |
- Americas Pharmaceutical Market Forecasts to 2018 | Industry Shares, Size, Trend, Analysis, and Forecasts to 2018 Report Available Online by Researchmoz.us |
- China Pharmaceutical Equipment Industry Report, 2012-2015 |
- Jones Engineering Group To Focus on Saudi's FMCG and Pharma Industries |
- Research and Markets: China Pharmaceutical Directory 2014 |
- Astellas To Form Strategic Partnership With ClearPath To Build Vaccine Portfolio |
- Johnson & Johnson Innovation Expands Global Incubator Presence to Israel and Announces Multiple, Diverse, Early-Stage Collaborations with Academia and Biotech |
- PHARM Connect Congress- One step before the future |
- Pharmaceutical Business Confidence Report Q4 2013 |
- SPI Pharma Launches Pharmaburst(R) 500 Microsite |
- Strategic Protein Formulation & Drug Delivery |
- Advanced S&OP for Life Sciences |
- Recro Pharma Announces Dosing of First Patient in Phase II REC-14-013 Clinical Trial of Dex-IN for Treatment of Acute Pain on Day 1 Following Surgery |
Suppliers of the Month
Thursday, October 30, 2014
Novo Nordisk, a global pharmaceutical company that produces medicines for patients with diabetes, hemophili..
Tuesday, October 07, 2014
Introduction West Pharmaceutical has announced its plans to expand its global manufacturing operat..
Recro Pharma Announces Dosing of First Patient in Phase II REC-14-013 Clinical Trial of Dex-IN for Treatment of Acute Pain on Day 1 Following Surgery
Wednesday, October 29, 2014
Recro Pharma, Inc. (REPH), a clinical stag..
Aptar Pharma recently hosted an expert panel roundtable on Inhaler Adherence This international scientific forum was held in Paris..
Kantonsspital Bruderholz (Kantonsspital) is a healthcare company. The company provides medical treat..